Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01131260 · ClinicalTrials.gov registry record · NA
Fetal ST Segment and T Wave Analysis in Labor
A NA study of Pregnancy and Obstetric Labor, sponsored by The George Washington University Biostatistics Center.
- Completed
- Registry status
- NA
- Development phase
- 11,108
- Enrollment target
- 13
- Study locations
NCT01131260 is a NA study of Pregnancy and Obstetric Labor that has completed, run by The George Washington University Biostatistics Center. The registered enrollment target is 11,108 participants, above the 815-participant average among 191 other Pregnancy trials with a reported enrollment target (1263% higher). The trial reports 13 study locations across 11 states.
The verdict
NCT01131260, a NA study of Pregnancy and Obstetric Labor, has completed, sponsored by The George Washington University Biostatistics Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 11,108 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of this research is to test a new instrument, called a fetal STAN monitor, that may be used during labor to monitor the electrical activity of the baby's heart. This new instrument is designed to help the doctor determine how well the baby is doing during labor. It will be used along with the existing electronic fetal monitor used to measure the baby's heart rate and the mother's contractions during birth. The specific purpose of this research study is to see if this new instrument (fetal STAN monitor) will have an impact on newborn health.
Conditions Studied
Interventions
- DEVICE fetal STAN monitor
Study Locations (13)
Ohio
- Case Western University - Cleveland
- Ohio State University - Columbus
Texas
- University of Texas - Galveston - Galveston
- University of Texas - Houston - Houston
Alabama
- University of Alabama - Birmingham - Birmingham
Illinois
- Northwestern University - Chicago
Michigan
- Wayne State University - Hutzel Hospital - Detroit
New York
- Columbia University - New York
North Carolina
- University of North Carolina - Chapel Hill - Chapel Hill
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,108 participants |
| Start Date | 2010-11 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01131260
The ClinicalTrials.gov registry entry for NCT01131260 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11,108 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 815-participant average among 191 other Pregnancy trials with a reported enrollment target (1263% higher). The listed sponsor is The George Washington University Biostatistics Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which fetal STAN monitor is the first listed.
NCT01131260 reports 13 study locations spanning 11 distinct geographic areas - top geographies include Ohio, Texas, Alabama.
Frequently Asked Questions
What is clinical trial NCT01131260 about?
NCT01131260 is a clinical study titled "Fetal ST Segment and T Wave Analysis in Labor". The purpose of this research is to test a new instrument, called a fetal STAN monitor, that may be used during labor to monitor the electrical activity of the baby's heart. This new instrument is designed to help the doctor determine how well the baby is doing during labor. It will be used along wit...
What is the current status of trial NCT01131260?
This trial is currently completed. It is a NA study. The enrollment target is 11,108 participants. The study started on 2010-11. Estimated completion is 2014-08.
What conditions does trial NCT01131260 study?
This clinical trial studies the following conditions: Pregnancy, Obstetric Labor, Parturition.
What interventions are being tested in trial NCT01131260?
The interventions under investigation include: fetal STAN monitor (DEVICE).
Who is sponsoring clinical trial NCT01131260?
This trial is sponsored by The George Washington University Biostatistics Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01131260 being conducted?
This trial has 13 study locations across Alabama, Illinois, Michigan, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Mitigating Response to Stressors in Pregnant Women
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.